Inhibitory Antibodies
抑制性抗体(Inhibitory Antibodies,常被称为中和抗体或阻断抗体)是一种能够特异性结合目标分子(如受体、酶或细胞因子),并直接抑制或阻断其正常生物学功能的特异性抗体。
| 货号 | 产品 | 反应 | 应用 | 偶联 | 引用 |
|---|---|---|---|---|---|
| BF6300 | Lenzilumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6301 | Carlumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6302 | Gevokizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6303 | Briakinumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6304 | Lebrikizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6305 | Denecimig | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6306 | Ublituximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6307 | Opicinumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6308 | Grisnilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6309 | Camrelizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6310 | Blontuvetmab | Canlupfam | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6311 | Omodenbamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6312 | Osemitamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6313 | Lixudebart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6314 | LM-305 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6315 | Vandortuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6316 | Moxetumomab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6317 | Pamlectabart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6318 | Elgemtumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6319 | Patecibart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6320 | Vixticibart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6321 | Tegoprubart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |